Kyle Gano, CEO: Neurocrine Biosciences NBIX Planned sale · Filed 01/16

Trade details

Type: Planned sale notice
Stock: Neurocrine Biosciences NBIX
Person: Kyle GanoCEO
Planned sale date: 26/01/16
Filed: 26/01/16

More to sell after $42.6K in 3 months

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 25/12/17~02/15

Kyle Gano's recent trades

Kyle GanoCEO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$4.6M
34,588 sh
$4.6M
Filed 01/20
Traded 01/16
Kyle GanoCEO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$240.5K
1,812 sh
$240.5K
Filed 01/20
Traded 01/16
Kyle GanoCEO
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$42.6K
300 sh
$42.6K
Filed 25/11/05
Traded 25/11/04
Kyle GanoCEO
SellNeurocrine Biosciences
Sell
Neurocrine Biosciences
NBIX
$42.6K
300 sh
$42.6K
Filed 25/11/04
Traded 25/11/04
Kyle GanoCEO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$158K
1,352 sh
$158K
Filed 25/02/14
Traded 25/02/13

Kyle Gano, CEO — plans to sell 36,400 sh of Neurocrine Biosciences NBIX · $4.9M · around 01/16 · 10b5-1 plan | Whalegun